These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10557546)

  • 41. Cadmium, lead, and thallium in smoke particulate from counterfeit cigarettes compared to authentic US brands.
    Pappas RS; Polzin GM; Watson CH; Ashley DL
    Food Chem Toxicol; 2007 Feb; 45(2):202-9. PubMed ID: 17011104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FDA claims nicotine levels were manipulated.
    Gavaghan H
    Nature; 1994 Jun; 369(6483):696. PubMed ID: 8008051
    [No Abstract]   [Full Text] [Related]  

  • 43. You might as well smoke; the misleading and harmful public message about smokeless tobacco.
    Phillips CV; Wang C; Guenzel B
    BMC Public Health; 2005 Apr; 5():31. PubMed ID: 15811179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Animal cloning and the FDA--the risk assessment paradigm under public scrutiny.
    Rudenko L; Matheson JC; Sundlof SF
    Nat Biotechnol; 2007 Jan; 25(1):39-43. PubMed ID: 17211392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention and control of food safety risks: the role of governments, food producers, marketers, and academia.
    Lupien JR
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():74-9. PubMed ID: 17392080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The scientific basis of tobacco product regulation.
    WHO Study Group
    World Health Organ Tech Rep Ser; 2007; (945):1-112, back cover. PubMed ID: 17802809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Research priorities and infrastructure needs of the Family Smoking Prevention and Tobacco Control Act: science to inform FDA policy.
    Leischow SJ; Zeller M; Backinger CL
    Nicotine Tob Res; 2012 Jan; 14(1):1-6. PubMed ID: 22184581
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of scientific evidence of risks and benefits in determining risk management policies for medications.
    Andrews E; Dombeck M
    Pharmacoepidemiol Drug Saf; 2004 Sep; 13(9):599-608. PubMed ID: 15362082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
    Leghorn J; Brophy E; Rother P
    Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466
    [No Abstract]   [Full Text] [Related]  

  • 50. Status of nutrition labeling, health claims, and nutrient content claims for processed foods: 1997 Food Label and Package Survey.
    Brecher SJ; Bender MM; Wilkening VL; McCabe NM; Anderson EM
    J Am Diet Assoc; 2000 Sep; 100(9):1057-62. PubMed ID: 11019354
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In search of the less hazardous cigarette.
    Givel M
    Int J Health Serv; 2011; 41(1):77-94. PubMed ID: 21319722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tobacco and nicotine product testing.
    Hatsukami DK; Biener L; Leischow SJ; Zeller MR
    Nicotine Tob Res; 2012 Jan; 14(1):7-17. PubMed ID: 21460383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Responding rapidly to FDA drug withdrawals: design and application of a new approach for a consumer health website.
    Embi PJ; Acharya P; McCuistion M; Kishman CP; Haag D; Marine S
    J Med Internet Res; 2006 Sep; 8(3):e16. PubMed ID: 17032632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brave new world in tobacco product design.
    Slade J
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):965-6. PubMed ID: 9829703
    [No Abstract]   [Full Text] [Related]  

  • 55. The regulatory status of talc.
    Gilbertson WE
    Regul Toxicol Pharmacol; 1995 Apr; 21(2):230-2. PubMed ID: 7644710
    [No Abstract]   [Full Text] [Related]  

  • 56. Clearing the smoke: the science base for tobacco harm reduction--executive summary.
    Stratton K; Shetty P; Wallace R; Bondurant S
    Tob Control; 2001 Jun; 10(2):189-95. PubMed ID: 11387543
    [No Abstract]   [Full Text] [Related]  

  • 57. Ignition strength of 25 international cigarette brands.
    Seidenberg AB; Rees VW; Alpert HR; O'Connor RJ; Connolly GN
    Tob Control; 2011 Jan; 20(1):77-80. PubMed ID: 20974622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reports of leaky gloves spur FDA to take action.
    Higgins LC
    Med World News; 1989 Jan; 30(2):43. PubMed ID: 10294480
    [No Abstract]   [Full Text] [Related]  

  • 59. Claims in vapour device (e-cigarette) regulation: A Narrative Policy Framework analysis.
    O'Leary R; Borland R; Stockwell T; MacDonald M
    Int J Drug Policy; 2017 Jun; 44():31-40. PubMed ID: 28414981
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Consumer perception of risk associated with filters contaminated with glass fibers.
    Cummings KM; Hastrup JL; Swedrock T; Hyland A; Perla J; Pauly JL
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):977-9. PubMed ID: 11008918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.